Dan Maller
Head of Investor Relations, B1 Medicines
Replay available
BeOne Medicines Ltd. (ONC) Q4 2025 Earnings Call
BeOne Medicines Ltd. (NASDAQ: ONC) Q4 2025 earnings conference call, held 2026-02-26. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
John Euler
Co-Founder, Chairman and CEO, B1 Medicines
Aaron Rosenberg
Chief Financial Officer, B1 Medicines
Lai Wong
President and Global Head of R&D, B1 Medicines
Michael Schmidt
Analyst, Guggenheim Partners
Yaron Werber
Analyst, Cohen
Matt Chalas
General Manager, North America, B1 Medicines
Xiaobin Wu
President and Chief Operating Officer, B1 Medicines
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Beone Medicines Ltd. Class A.
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:06.180 Good day, everyone. Welcome to B1 Medicine's Q4 and full year 2025 00:00:06.180 -- 00:00:11.548 earnings call webcast. All lines have been placed on mute to prevent any background 00:00:11.548 -- 00:00:17.437 noise. After the speaker's remarks, there will be a question and answer session. 00:00:17.437 -- 00:00:22.101 At this time, I would like to turn the call over to the company. 00:00:22.880 -- 00:00:25.145 Hello and welcome. Thanks for joining us today. 00:00:25.145 -- 00:00:28.913 I'm Dan Maller, head of investor relations at B1 Medicines. 00:00:28.913 -- 00:00:33.883 Before we begin, please note that you can find additional materials, including a replay 00:00:33.883 -- 00:00:38.533 of today's webcast and presentation on the investor relations section of our website, 00:00:38.533 -- 00:00:40.533 ir.b1medicines.com. 00:00:41.324 -- 00:00:45.128 I would like to remind all participants that during this call, we may make forward-looking 00:00:45.128 -- 00:00:49.213 statements regarding, among other things, the company's future prospects and business 00:00:49.213 -- 00:00:54.619 strategy. Actual results may differ materially from those indicated in the forward-looking 00:00:54.619 -- 00:00:59.285 statements as a result of various factors, including those risks discussed in our most 00:00:59.285 -- 00:01:02.969 recent periodic report filed with the SEC. 00:01:02.969 -- 00:01:06.413 Please also carefully review the forward-looking statements disclaimer on the slide deck 00:01:06.413 -- 00:01:09.168 that accompanies this presentation. 00:01:09.168 -- 00:01:13.474 Reconciliations between GAAP and non-GAAP financial measures discussed on this call are 00:01:13.474 -- 00:01:17.901 provided in the appendix to our presentation, which is pos...